Prosecution Insights
Last updated: October 04, 2026

Technische Universität München

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

24 pending office actions • 16 art units • 23 examiners • 0 of 24 (0%) have an AI response strategy ready • 16 patents granted in the last 365 days

Analysis

Technische Universität München maintains a portfolio with 23 pending office actions, primarily focused within the Biotechnology & Pharmaceuticals technology area. This volume is distributed across 22 distinct examiners, indicating a decentralized prosecution strategy where individual examiner tendencies vary. The involvement of 16 distinct art units further suggests a broad technical scope within the university's research output, requiring practitioners to adapt to many different departmental standards.

SYLVESTER, KEVIN serves as the busiest examiner for this portfolio, currently managing 2 pending office actions. While this represents the highest concentration for a single official, the remaining matters are spread among other examiners. This distribution means that 22 distinct examiners are influencing the outcome of the 23 pending actions, leaving little room for examiner-specific trends to dominate the overall portfolio strategy. Practitioners should prepare for diverse procedural requirements given that the 16 distinct art units represent a high degree of departmental variety across the biotechnology sector.

The count of 16 distinct art units relative to the total workload implies that the university's biotechnology and pharmaceutical filings are not concentrated in a single niche but are instead spread across various specialized divisions. This complexity necessitates a case-by-case approach to prosecution, as the 22 distinct examiners will likely apply different levels of rigor based on their specific art unit's guidelines. Successfully navigating these matters will require a deep understanding of the unique technical and administrative expectations of each involved department.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

24
Total Pending OAs
14
Non-Final OAs
10
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

7
Overdue
0
Due this week
2
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (7)Due ≤ 30 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

12
Hard (50%)
11
Medium (46%)
1
Easy (4%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only8 (33%)
§102 only1 (4%)
§112 only1 (4%)
Double-patenting + other2 (8%)
Multi-statute (no §101)12 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

16
Life Sciences
67% of docket
0
Information Tech
0% of docket
1
Communications
4% of docket
0
Semiconductors
0% of docket
3
Mechanical / Eng
12% of docket
4
Business / Other
17% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

240 h
Manual time on pending OAs
48 h
Time saved (low, 20%)
84 h
Time saved (mid, 35%)
2.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SYLVESTER, KEVIN 2 47.5% +27.4%
QURESHI, MOHAMMED AHMED 1 82.7% +13.4%
BUKSA, CHRISTOPHER ALLEN 1 73.6% +20.1%
WRIGHT, ALEXANDER SCOTT 1 73.5% -0.6%
GROUX, JENNIFER LILA 1 34.8% +39.3%
ROBINSON, HOPE A 1 67.7% +43.1%
LANGHALS, RENEE C 1 58.3% +43.0%
ORDUNA, TAMARA 1 — —
DODDS, SCOTT 1 68.1% +34.5%
LANKFORD JR, LEON B 1 70.0% +31.6%

Hard Cases (12)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18029516 BIOORTHOGONAL REPORTER GENE SYSTEM BATES, KEENAN ALEXANDER 18d overdue
18682872 FLUID VESSEL AND MANUFACTURING METHOD FOR A FLUID VESSEL DODDS, SCOTT 16d overdue
18711692 MULTI-DIMENSIONAL TOOL ADJUSTMENT BASED ON ACOUSTIC SIGNAL LANGHALS, RENEE C 15d overdue
18832700 METHOD AND DEVICE FOR ADDITIVELY MANUFACTURING AN OBJECT GROUX, JENNIFER LILA 15d
18863057 AC-FIELD DRIVEN MACROMOLECULAR ROTARY MOTOR QURESHI, MOHAMMED AHMED —
18833309 MANUFACTURING DEVICE FOR MANUFACTURING OBJECTS IN LAYERS WRIGHT, ALEXANDER SCOTT —
18719148 A METHOD FOR GENETIC MODIFICATION FOR HIGH GC CONTENT MICROORGANISMS ROBINSON, HOPE A —
18280325 TREATMENT OF CORONAVIRUS INFECTIONS USING SAM CYCLE INHIBITORS NEAGU, IRINA —

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18862947 MODULAR ROBOTIC SYSTEM BUKSA, CHRISTOPHER ALLEN 31d overdue
18269359 COATED MEMBRANE FOR WATER ELECTROLYSIS SYLVESTER, KEVIN 23d overdue
18682872 FLUID VESSEL AND MANUFACTURING METHOD FOR A FLUID VESSEL DODDS, SCOTT 16d overdue
18711692 MULTI-DIMENSIONAL TOOL ADJUSTMENT BASED ON ACOUSTIC SIGNAL LANGHALS, RENEE C 15d overdue
18832700 METHOD AND DEVICE FOR ADDITIVELY MANUFACTURING AN OBJECT GROUX, JENNIFER LILA 15d
18863057 AC-FIELD DRIVEN MACROMOLECULAR ROTARY MOTOR QURESHI, MOHAMMED AHMED —
18719148 A METHOD FOR GENETIC MODIFICATION FOR HIGH GC CONTENT MICROORGANISMS ROBINSON, HOPE A —
18291943 DETECTION OF MOLECULAR BIOLOGICAL OBJECTS, CELLULAR BIOLOGICAL OBJECTS AND CELL AGGREGATES USING QUANTITATIVE PHASE-CONTRAST MICROSCOPY LANKFORD JR, LEON B —

Top Art Units

Art UnitApps
1612 3
1618 2
1794 2
3658 1
1745 1
1754 1
1652 1
3797 1
1746 1
1657 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18863057 AC-FIELD DRIVEN MACROMOLECULAR ROTARY MOTOR QURESHI, MOHAMMED AHMED — §102§103§112 Non-Final OA — Pending Nov 05, 2024
18862947 MODULAR ROBOTIC SYSTEM BUKSA, CHRISTOPHER ALLEN 3658 §103 Final Rejection 31d overdue Pending Nov 04, 2024
18833309 MANUFACTURING DEVICE FOR MANUFACTURING OBJECTS IN LAYERS WRIGHT, ALEXANDER SCOTT 1745 §102§103§112 Final Rejection — Pending Jul 25, 2024
18832700 METHOD AND DEVICE FOR ADDITIVELY MANUFACTURING AN OBJECT GROUX, JENNIFER LILA 1754 §102§103 Final Rejection 15d Pending Jul 24, 2024
18719148 A METHOD FOR GENETIC MODIFICATION FOR HIGH GC CONTENT MICROORGANISMS ROBINSON, HOPE A 1652 §103§112 Final Rejection — Pending Jun 12, 2024
18711692 MULTI-DIMENSIONAL TOOL ADJUSTMENT BASED ON ACOUSTIC SIGNAL LANGHALS, RENEE C 3797 §103§112 Non-Final OA 15d overdue Pending May 20, 2024
18690856 PROCESS FOR THE MANUFACTURE OF A COATED CATHODE ACTIVE MATERIAL, AND COATED CATHODE ACTIVE MATERIAL ORDUNA, TAMARA — §103 Final Rejection — Pending Mar 11, 2024
18682872 FLUID VESSEL AND MANUFACTURING METHOD FOR A FLUID VESSEL DODDS, SCOTT 1746 §103§112 Non-Final OA 16d overdue Pending Feb 09, 2024
18291943 DETECTION OF MOLECULAR BIOLOGICAL OBJECTS, CELLULAR BIOLOGICAL OBJECTS AND CELL AGGREGATES USING QUANTITATIVE PHASE-CONTRAST MICROSCOPY LANKFORD JR, LEON B 1657 §103 Non-Final OA — Pending Jan 25, 2024
18291952 DETECTION OF CELL AGGREGATES USING QUANTITATIVE PHASE-CONTRAST MICROSCOPY BAYNES, SAMUEL DAVID 2665 §103Other Final Rejection 4d overdue Pending Jan 25, 2024
18570451 PORTABLE TESTING DEVICE FOR TESTING SUSCEPTIBILITY OF A BIOLOGICAL PROBE TO ONE OR MORE BIOACTIVE SUBSTANCES BOWERS, NATHAN ANDREW — §103 Final Rejection — Pending Dec 14, 2023
18286003 NUCLEIC ACID ORIGAMI PLATFORMS AND THEIR USES SCHLIENTZ, LEAH H 1618 §102 Non-Final OA — Pending Oct 06, 2023
18280325 TREATMENT OF CORONAVIRUS INFECTIONS USING SAM CYCLE INHIBITORS NEAGU, IRINA 1629 §102§103§112 Non-Final OA — Pending Sep 05, 2023
18546311 DUAL MODE RADIOTRACER AND THERAPEUTICS MOSHER, ERIC PARKER 1612 §112Other Non-Final OA 28d Pending Aug 14, 2023
18276802 CXCR4-LIGANDS FOR DIAGNOSTIC AND THERAPEUTIC USE AND PRECURSORS THEREOF RONEY, CELESTE A 1612 §103§112DP Non-Final OA — Pending Aug 10, 2023
18269359 COATED MEMBRANE FOR WATER ELECTROLYSIS SYLVESTER, KEVIN 1794 §103 Final Rejection 23d overdue Pending Jun 23, 2023
18269088 CONDITIONAL CELL CONNECTORS KIM, YUNSOO 1641 §102§103DP Non-Final OA — Pending Jun 22, 2023
18256101 IRIDIUM-CONTAINING CATALYST FOR WATER ELECTROLYSIS SYLVESTER, KEVIN 1794 §103§112 Non-Final OA — Pending Jun 06, 2023
18252861 NETWORK STATE MODELLING ALHIJA, SAIF A — §102§112 Non-Final OA — Pending May 12, 2023
18031759 METHANATION WITH TURBOCHARGER LEUNG, JENNIFER A 1774 §103§112 Non-Final OA — Pending Apr 13, 2023
18029516 BIOORTHOGONAL REPORTER GENE SYSTEM BATES, KEENAN ALEXANDER 1631 §102§103§112 Final Rejection 18d overdue Pending Mar 30, 2023
17910728 CYCLIC PEPTIDES AND THEIR CONJUGATES FOR ADDRESSING ALPHA-V-BETA-6 INTEGRIN IN VIVO WEBB, WALTER E 1612 §103 Final Rejection 37d overdue Pending Sep 09, 2022
17770764 Theragnostic Endoprosthetic Spacer DUDDEN, TERESA MARIE 3774 §103§112 Non-Final OA — Pending Apr 21, 2022
17768706 COMPOUNDS WITH IMPROVED PHARMACOKINETICS FOR IMAGING AND THERAPY OF CANCER PERREIRA, MELISSA JEAN 1618 §103 Non-Final OA — Pending Apr 13, 2022

Managing Technische Universität München's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month